|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
| European Pharmaceutical Industry |
|
|
|
|
€ 600,00 |
Editeur
: |
Rocsearch |
Langue
: |
Anglais |
Date de publication : |
Juillet 2002 |
Taille du document : |
35 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (2) |
|
|
|
| 56 pages | Février 2007 | Anglais
|
|
|
| Main
focus: |
pharmaceutical,pharmaceutical industry,...,...
|
| Research
focus: |
pricing policy,market definition, |
| Geographic
focus: |
australia,france,usa,spain,ireland,italy,... |
| |
|
|
|
|
| 158 pages | Juin 2005 | Anglais
|
|
|
| Main
focus: |
pharmaceutical,pharmaceutical industry,...,...
|
| Research
focus: |
industry structure,distribution channels, |
| Geographic
focus: |
usa,france,china,italy,japan,united kingdom,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
ePharmacies: Strategic Implications for the Healthcare Industry
230 pages | Mars 2000 |
Increasingly, the pharmaceutical sector is being influenced by the Internet.Are you in a position to:- Predict future shifts in drug prescribing and purchasing behavior?- Anticipate consolidation in b |
955,00 €
|
| |
| |
The Global Parallel Trade Outlook 2001 - 2006: A Country-by-Country Analysis
188 pages | Septembre 2001 |
Global Parallel Trade Outlook 2001: A country-by-country analysis, a new report by Reuters Business Insight, provides a detailed update on the status of parallel trade in the global marketplace.
1 200,00 €
|
|
| |
| |
Pharmaceutical Pricing Strategies 2000: Entering the new millennium
240 pages | Juin 2000 |
The favorable climate of the pharmaceutical sector has changed radically over the past ten years.
Where once a company's freedom over pricing decisions was almost limitless, external pressure |
955,00 €
|
| |
| |
Pharmaceutical Packaging: UK
90 pages | Avril 2000 |
· Analyse the changes in demand for pharmaceutical packaging in the UK, over the next 5 years
· Understand the main factors affecting demand
· Examine the struct |
1 249,31 €
|
| |
| |
Healthcare In Wales
50 pages | Mai 2000 |
The Welsh Presentation Includes:- The Structure Of The NHS In Wales- Revenue Expenditure On Health Services In Wales- Number Of Hospital Units - Number Of Available Inpatient Beds- Number Of Occupied |
327,00 €
|
| |
| |
The Evolution of DTC marketing across key pharmaceutical markets
152 pages | Mars 2000 |
Pharmaceutical companies mainly market their products through contact between their sales force and heathcare providers.
However, due to the nature of its products, the pharmaceutical industry |
955,00 €
|
| |
| |
Strategic Intelligence: The Top 12 Pharmaceutical Companies
158 pages | Novembre 2001 |
The pressure on the pharmaceutical company R&D has never been greater.
It is estimated that $100 billion worth of products will face patent expiry by 2005.
Of this, $37 billion represe |
1 021,89 €
|
| |
| |
The Pharmaceutical industry in the 21st Century
150 pages | Octobre 1998 |
Does the 21st century herald the beginning of a genomics revolution? Which disease areas will provide the greatest growth potential and why? Which technologies have the greatest potential to max |
795,00 €
|
| |
| |
The Drug Delivery Outlook to 2005
150 pages | Février 1999 |
Strategic overview : defines and values the market covered in the report, provides a macro analysis of the reasons why the drug delivery sector is growing at current rates and predicts how the c |
795,00 €
|
| |
| |
Regulatory Affairs: Paths to Approval
113 pages | Février 1999 |
Area Specific Chapters : The regulatory systems governing clinical trials and drug approvals are examined for the US, Europe, and Australia, Canada and Japan, including analysis of the implicatio |
795,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| European Pharmaceutical Industry |
|
|
The Pharmaceutical industry remains one of Europe’s best performing sectors (employment, R&D and trade surplus). The world pharmaceutical market was worth an estimated € 392,640 million (at ex-factory prices) in 2000. The North American market (USA & Canada) grew fastest and remained the world’s largest market with a 43.0% share, well ahead of Europe and Japan. Constraints on the industry have tightened in recent years, despite the fact that on average, pharmaceutical spending accounts for less than 15% of total health expenditure. In contrast with the US, the pharmaceutical industry in Europe is faced with pricing issues and reimbursement regulations. According to 1999 IMS data, 57% of sales of new medicines marketed since 1995 are generated in the US market, compared with 25% in the European market.
Against this background, the report explores the prospects for the European Pharmaceutical Industry. It focuses on the trends, structure, spending, production & sales and R&D in the Pharmaceutical Industry in Europe.
|
|
|
PPLSEN
|
|
|
|
|
